- Home
- HCTI vs XBIO Comparison
HCTI vs XBIO Comparison
Compare HCTI & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- XBIO
- Stock Information
- Founded
- HCTI 2020
- XBIO N/A
- Country
- HCTI United States
- XBIO United States
- Employees
- HCTI N/A
- XBIO N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- XBIO Health Care
- Exchange
- HCTI Nasdaq
- XBIO Nasdaq
- Market Cap
- HCTI 6.8M
- XBIO 5.8M
- IPO Year
- HCTI 2021
- XBIO N/A
- Fundamental
- Price
- HCTI $1.16
- XBIO $3.66
- Analyst Decision
- HCTI
- XBIO Hold
- Analyst Count
- HCTI 0
- XBIO 1
- Target Price
- HCTI N/A
- XBIO N/A
- AVG Volume (30 Days)
- HCTI 8.2M
- XBIO 30.0K
- Earning Date
- HCTI 11-26-2024
- XBIO 11-12-2024
- Dividend Yield
- HCTI N/A
- XBIO N/A
- EPS Growth
- HCTI N/A
- XBIO N/A
- EPS
- HCTI N/A
- XBIO N/A
- Revenue
- HCTI $16,565,999.00
- XBIO $2,523,427.00
- Revenue This Year
- HCTI $88.31
- XBIO N/A
- Revenue Next Year
- HCTI N/A
- XBIO N/A
- P/E Ratio
- HCTI N/A
- XBIO N/A
- Revenue Growth
- HCTI N/A
- XBIO 7.15
- 52 Week Low
- HCTI $0.29
- XBIO $2.78
- 52 Week High
- HCTI $4.45
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- HCTI 62.52
- XBIO 45.78
- Support Level
- HCTI $1.17
- XBIO $3.58
- Resistance Level
- HCTI $1.28
- XBIO $4.60
- Average True Range (ATR)
- HCTI 0.14
- XBIO 0.41
- MACD
- HCTI -0.02
- XBIO -0.02
- Stochastic Oscillator
- HCTI 7.14
- XBIO 7.48
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments which are Software Services, Managed Services, and Support and Platform Services.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.